¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myelo"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myelogenous
    1. °ñ¼ö(±â¿ø)- 2. °ñ¼öÇü¼º-
  • myelogenous leukemia
    °ñ¼ö¼º¹éÇ÷º´
  • myelogeny
    ¸»ÀÌÁý¼º¼÷, ¼öÃÊÇü¼º
  • myelogram
    ô¼öÁ¶¿µ»ó
  • myelography
    ô¼öÁ¶¿µ(¼ú)
  • myeloid
    °ñ¼ö¸ð¾ç-, °ñ¼ö¼º
  • myeloid cell
    °ñ¼ö¼¼Æ÷
  • myeloid metaplasia
    °ñ¼öÈ­»ý
  • myelolipoma
    °ñ¼öÁö¹æÁ¾
  • myeloma
    °ñ¼öÁ¾
  • myeloma cell
    °ñ¼öÁ¾¼¼Æ÷
  • myeloma globulin
    °ñ¼öÁ¾±Û·ÎºÒ¸°
  • myeloma kidney
    °ñ¼öÁ¾ÄáÆÏ, °ñ¼öÁ¾½ÅÀå
  • myeloma nephrosis
    °ñ¼öÁ¾ÄáÆÏÁõ, °ñ¼öÁ¾½ÅÀåÁõ
  • myelomalacia
    ô¼ö¿¬È­(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myelogenous
    °ñ¼ö-
  • myelogenous leukemia
    °ñ¼ö¹éÇ÷º´
  • myelogeny
    ¸»ÀÌÁý¼º¼÷
  • myelogram
    ô¼öÁ¶¿µ»ó
  • myelography
    ô¼öÁ¶¿µ¼ú
  • myeloid
    °ñ¼ö¸ð¾ç-
  • myeloid cell
    (¢¡marrow cell) °ñ¼ö¼¼Æ÷
  • myeloid metaplasia
    °ñ¼öÈ­»ý
  • myelolipoma
    °ñ¼öÁö¹æÁ¾
  • myeloma
    °ñ¼öÁ¾
  • myeloma cell
    °ñ¼öÁ¾¼¼Æ÷
  • myeloma globulin
    °ñ¼öÁ¾±Û·ÎºÒ¸°
  • myeloma kidney
    °ñ¼öÁ¾ÄáÆÏ
  • myeloma nephrosis
    °ñ¼öÁ¾ÄáÆÏÁõ
  • myelomalacia
    ô¼ö¿¬È­(Áõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myelocele
    ô¼öÅ»ÃâÁõ
  • myelocele
    ô¼ö·ù(ô±âÐ×»)
  • myeloclast
    ¼öÃÊÆÄ±«¼¼Æ÷(âÐôú÷òÎÕá¬øà).
  • myelocone
    ³úÁö¹æÁú(Òàò·Û¸òõ).
  • myelocrit
    ¹Ì¿¤·ÎÅ©¸®Æ®, °ñ¼ö¾×ºñ·®°ü(ÍéâÐäûÝïåÖη).
  • myelocyst
    ô¼ö³¶.
  • myelocyst
    ô¼ö³¶(ô±âÐÒ¥)
  • myelocystocele
    ô¼ö³¶·ù.
  • myelocystocele
    ô¼ö³¶·ù(¡­×»)
  • myelocystomeningocele
    ô¼ö³¶¼ö¸··ù.
  • myelocystomeningocele
    ô¼ö³¶¼ö¸··ù(¡­âÐØ¯×»)
  • myelocyte
    °ñ¼ö¼¼Æ÷(ÍéâÐá¬øà), °ñ¼ö±¸(ÍéâÐϹ).
  • myelocyte
    °ñ¼ö¼¼Æ÷ »À¼ÓÁú¼¼Æ÷
  • myelocyte
    °ñ¼ö¼¼Æ÷(Ë­ËàËṴ̂), °ñ¼ö±¸(Ë­ËàË´).
  • myelocyte
    °ñ¼ö¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
MPO Myelo-Per-Oxidase
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • G99.2*
    Myelopathy in diseases classified elsewhere
    ´Þ¸® ºÐ·ùµÈ Áúȯ¿¡¼­ÀÇ Ã´¼öº´Áõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myelofibrosis
    °ñ¼ö ¼¶À¯Áõ
    °ñ¼ö Á¶Á÷ÀÇ ¼¶À¯°¡ °úÀ× ¹ßÀ°µÈ »óÅÂ. ÀÌ °°Àº Áõ»ó¿¡¼­´Â Á¤»óÀûÀÎ Á¶Ç÷ Á¶Á÷ÀÌ Àû¾îÁö°í ºñÀåÀ̳ª ±× ¹ÛÀÇ ¼¼¸Á³»ÇǰèÀÇ Á¶Á÷¿¡µµ Ç÷¾× ¼¼Æ÷°¡ Çü¼ºµÈ´Ù. Ç÷¾×¿¡¼­´Â Á¤»ö¼º ºóÇ÷ÀÌ ÀÖÀ¸¸ç, Ç÷¼ÒÆÇÀÌ Á¤»óÀÏ ¶§µµ ÀÖÀ¸³ª °¨¼ÒµÇ¾î ÃâÇ÷À» ÀÏÀ¸Å°´Â Àϵµ ÀÖ´Ù. ¹éÇ÷±¸ÀÇ ¼ö´Â ÀÏÁ¤ÇÏÁö ¾Ê°í Àû¾Æ¼¼Æ÷³ª ¹Ì¼÷ÇÑ ¹éÇ÷±¸°¡ Ç÷¾× ¼Ó¿¡ ³ªÅ¸³­´Ù. ¶Ç ºñÀåÀÌ ºÎ¾î¼­ ¹éÇ÷º´°ú ºñ½ÁÇÑ Â¡Èĸ¦ º¸ÀδÙ. ¿øÀÎÀÌ ºÐ¸íÇÏÁö ¾ÊÀº °æ¿ì°¡ ÀÖÀ¸¸ç, ¹éÇ÷º´ÀÇ °æ°ú Áß¿¡ ¹ßº´ÇÏ´Â Àϵµ ÀÖ´Ù. ¶Ç ¹éÇ÷º´ À¯¿¬ Áúȯ, °áÇÙ, ¸Åµ¶¿¡¼­µµ »ý±â¸ç, ÀÌ ¹Û¿¡ ¿©·¯ °¡Áö µ¶¹°, Áï ¾Æ´Ò¸° ¿°·á, º¥Á¹, ³³, ºñ¼Ò, ÀÎ, Ç÷ç¿À¸£ µî¿¡ ÀÇÇÑ Áßµ¶ÀÌ ¿øÀÎÀÌ µÇ´Â °æ¿ìµµ ÀÖ´Ù. Áõ¼¼ÀÇ °æ°ú´Â ¿Ï¸¸Çϳª Àß ³´Áö ¾Ê´Â´Ù.
  • myelogenesis
    ³ú ô¼ö ¹ß»ý, ¸¶ÀÌ¿¤¸° ¹ß»ý
  • myelogenous
    °ñ¼ö¼ºÀÇ
  • myelogeny
    ¼öÃÊ ¹ß»ý
  • myelogonic
    °ñ¼ö¾Æ±¸¼ºÀÇ, °ñ¼ö¾Æ±¸ ¼¼Æ÷¼ºÀÇ
  • myelogram
    °ñ¼ö»ó
    µ¿ÀǾî=bone marrow
  • myelogram
    ô¼ö°­ Á¶¿µ»ó
  • myeloid
    °ñ¼ö¼º, °ñ¼öÁõ, °ñ¼ö¾çÀÇ
  • myeloid leukoses
    °ñ¼ö¼º ¹éÇ÷Áõ
  • myeloidosis
    °ñ¼ö Á¶Á÷ °úÇü¼º
    °ñ¼ö Á¶Á÷ÀÇ ¹ßÀ°, ƯÈ÷ ÀÌ °°Àº Á¶Á÷ÀÇ °úÇü¼º ¹ßÀ°.
  • myelolipoma
    °ñ¼ö Áö¹æÁ¾, ¼öÁú Áö¹æÁ¾
    ºÎ½ÅÀÇ µå¹® ¾ç¼º Á¾¾çÀ¸·Î¼­, Á÷°æÀÌ ¼ö cmÀ̸ç Áö¹æ Á¶Á÷, ¸²ÇÁ±¸ ¹× ¿ø½ÃÀûÀÎ °ñ¼ö¾ç ¼¼Æ÷°¡ ¿©·¯ °¡Áö ºñÀ²·Î ÀÌ·ç¾îÁø´Ù.
  • myelolysis
    ¸¶ÀÌ¿¤¸° ºØ±«
  • myeloma
    °ñ¼öÁ¾
    1. °ñ¼ö¿¡¼­ ¹ß°ßµÇ´Â Á¤»óÀûÀÎ Á¾·ùÀÇ ¼¼Æ÷·Î ±¸¼ºµÈ Á¾¾ç. 2. °ñ¼ö¼º ¼¼Æ÷¿¡¼­ ¹ß»ýÇÏ´Â Á¾¾ç. °ñ¼ö ¼¼Æ÷Á¾
  • myeloma globulin
    °ñ¼öÁ¾ ±Û·ÎºÒ¸°
  • myelomalacia
    ô¼ö ¿¬È­
    ô¼öÀÇ º´ÀûÀÎ ¿¬È­.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
myelocystocele Spina bifida containing spinal cord substance.
Origin: myelo-+ G. Kystis, bladder, + kele, tumour
(05 Mar 2000)
myelocystomeningocele <embryology> A congenital defect that is characterised by the protrusion of the membranes and cord through a defect in the vertebral column.
(27 Sep 1997)
myelocyte A motile cell produced by and found in the bone marrow which develops intogranular leukocytes.
(09 Oct 1997)
myelocyte A The youngest form of myelocyte, characterised by only a few (not more than ten) cytoplasmic granules, which are most reliably demonstrated by means of staining with neutral red; the mitochondria are numerous, and resemble those of the myeloblast.
(05 Mar 2000)
myelocyte B The intermediate form of myelocyte, characterised by approximately 30 to 100 (or more) cytoplasmic granules scattered among the mitochondria; the latter are less numerous than in myelocyte's of the A stage, and they are frequently displaced toward the periphery of the cell.
(05 Mar 2000)
myelocyte C The most mature of the myelocyte's characterised by numerous cytoplasmic granules that are recognizable as neutrophilic, eosinophilic, and basophilic; with neutral red these are stained, respectively, red, bright yellow, and deep maroon; C myelocyte's are frequently larger than earlier forms; if the nucleus is indented, the myelocyte is maturing into a metamyelocyte.
(05 Mar 2000)
myelocythemia The presence of myelocytes in the circulating blood, especially in persistently large numbers (as in myelocytic leukaemia).
Origin: myelocyte + G. Haima, blood
(05 Mar 2000)
myelocytic Pertaining to or characterised by myelocytes.
(05 Mar 2000)
myelocytic crisis A temporary but conspicuous and sudden increase in cells of the myelocytic series in the circulating blood.
(05 Mar 2000)
myelocytic leukaemia <haematology, tumour> A form of leukaemia characterised by an uncontrolled proliferation of myelopoietic cells in the bone marrow and in extramedullary sites, and the presence of large numbers of immature and mature granulocytic forms in various tissues (and organs) and in the circulating blood.
The total count may range from 1000 (aleukaemic variety) to several hundred thousand per cu mm. The predominant cell is usually of the neutrophilic series, but, in a few instances, eosinophilic or basophilic granulocytes, or even megakaryocytes, may represent the chief form; early in granulocytic leukaemia, the circulating blood may contain excessive numbers of all of the granulocytic forms.
Synonym: leukaemic myelosis, myelocytic leukaemia, myelogenic leukaemia, myelogenous leukaemia, myeloid leukaemia.
(05 Mar 2000)
myelocytic leukemoid reaction Leukocytosis of at least moderate degree, e.g., 50,000 or more per cu mm, with a few immature forms, e.g., 1 or 2% myelocytes, but chiefly mature polymorphonuclear leukocytes in the circulating blood; may be observed in association with tuberculosis, chronic osteomyelitis, various types of empyema, malaria, pneumococcal pneumonia, meningococcal meningitis, Hodgkin's disease, and metastases of carcinoma in the bone marrow.
(05 Mar 2000)
myelocytoma A nodular focus or fairly well-circumscribed, relatively dense accumulation of myelocytes, as in certain tissues of persons with myelocytic leukaemia.
Origin: myelocyte + G. -oma, tumour
(05 Mar 2000)
myelocytomatosis 1. A form of tumour involving chiefly the myelocytes.
Synonym: leukochloroma.
2. A rare leukosis of fowl marked by the presence of white tumours composed of myeloid cells, located principally along the sternum and in the liver.
(05 Mar 2000)
myelocytosis The occurrence of abnormally large numbers of myelocytes in the circulating blood, or tissues, or both.
Origin: myelocyte + G. -osis, condition
(05 Mar 2000)
myelodiastasis Softening and destruction of the spinal cord.
Origin: myelo-+ G. Diastasis, separation
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 2
  • Myeloid Cells - »õâ The classes of BONE MARROW-derived blood cells in the monocytic series (MONOCYTES and their precursors) and granulocytic series (GRANULOCYTES and their precursors).
    Synonyms : Cell, Myeloid, Cells, Myeloid, Myeloid Cell
  • Myeloid Differentiation Factor 88 - »õâ An intracellular signaling adaptor protein that plays a role in TOLL-LIKE RECEPTOR and INTERLEUKIN 1 RECEPTORS signal transduction. It forms a signaling complex with the activated cell surface receptors and members of the IRAK KINASES.
    Synonyms : MyD88 Protein, TLR Signal Adaptor Protein MyD88, Toll-Like Receptor Signal Adaptor Protein MyD88, Toll Like Receptor Signal Adaptor Protein MyD88
  • Myeloid Metaplasia - »õâ The occurrence of myeloid tissue in extramedullary sites. Specifically it is a syndrome characterized by splenomegaly, anemia, the presence of nucleated erythrocytes and immature granulocytes in the circulating blood, and extramedullary hematopoiesis in the liver and spleen. The primary form is also known as agnogenic myeloid metaplasia, myelosclerosis, and myelofibrosis. The secondary or symptomatic form may be associated with various diseases, including carcinomatosis, tuberculosis, leukemia, and polycythemia vera. (Dorland, 27th ed)
    Synonyms : Agnogenic Myeloid Metaplasias, Metaplasia, Agnogenic Myeloid, Metaplasia, Myeloid, Metaplasias, Agnogenic Myeloid, Metaplasias, Myeloid, Myeloid Metaplasia, Agnogenic, Myeloid Metaplasias, Myeloid Metaplasias, Agnogenic, Myeloses, Nonleukemic
  • Myeloid Progenitor Cells - »õâ One of the two stem cells derived from HEMATOPOIETIC STEM CELLS - the other being the lymphoid progenitor cell. Derived from these myeloid progenitor cells are the ERYTHROID PROGENITOR CELLS and the MYELOID CELLS; (MONOCYTES and GRANULOCYTES).
    Synonyms : Cell, Myeloid Progenitor, Cell, Myeloid Stem, Cells, Myeloid Progenitor, Cells, Myeloid Stem, Myeloid Progenitor Cell, Myeloid Stem Cell, Myeloid Stem Cells, Progenitor Cell, Myeloid, Progenitor Cells, Myeloid, Stem Cell, Myeloid
  • Myeloid-Lymphoid Leukemia Protein - »õâ Myeloid-lymphoid leukemia protein is a transcription factor that maintains high levels of HOMEOTIC GENE expression during development. The GENE for myeloid-lymphoid leukemia protein is commonly disrupted in LEUKEMIA and combines with over 40 partner genes to form FUSION ONCOGENE PROTEINS.
    Synonyms : Acute Lymphoblastic Leukemia Protein 1, MLL Proto-Oncogene Protein, Mixed-Lineage Leukemia Protein, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein, Proto-Oncogene Proteins MLL, Zinc Finger Protein HRX, MLL Proto Oncogene Protein
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
myeloid leukemia chronic myelocytic leukemia: chronic leukemia characterized by granular leukocytes; more common in older people
Ãâó: wordnet.princeton.edu/perl/webwn
myelogram X-ray film of the spinal cord and spinal nerve roots and subarachnoid space
Ãâó: wordnet.princeton.edu/perl/webwn
myelography roentgenography of the spinal cord to detect possible lesions (usually after injection of a contrast medium into the subarachnoid space)
Ãâó: wordnet.princeton.edu/perl/webwn
myeloid of or relating to bone marrow
Ãâó: wordnet.princeton.edu/perl/webwn
myeloma a tumor of the bone marrow (usually malignant) composed of cells normally found in bone marrow
Ãâó: wordnet.princeton.edu/perl/webwn
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 2
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á